Cargando…
TMED2 as a marker of prognosis in breast cancer [Letter]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636177/ https://www.ncbi.nlm.nih.gov/pubmed/31372042 http://dx.doi.org/10.2147/CMAR.S210756 |
| _version_ | 1783436021118009344 |
|---|---|
| author | Schwarz, Megan Catherine Allikmets, Silvia |
| author_facet | Schwarz, Megan Catherine Allikmets, Silvia |
| author_sort | Schwarz, Megan Catherine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6636177 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66361772019-08-01 TMED2 as a marker of prognosis in breast cancer [Letter] Schwarz, Megan Catherine Allikmets, Silvia Cancer Manag Res Letter Dove 2019-07-11 /pmc/articles/PMC6636177/ /pubmed/31372042 http://dx.doi.org/10.2147/CMAR.S210756 Text en © 2019 Schwarz and Allikmets. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Schwarz, Megan Catherine Allikmets, Silvia TMED2 as a marker of prognosis in breast cancer [Letter] |
| title | TMED2 as a marker of prognosis in breast cancer [Letter] |
| title_full | TMED2 as a marker of prognosis in breast cancer [Letter] |
| title_fullStr | TMED2 as a marker of prognosis in breast cancer [Letter] |
| title_full_unstemmed | TMED2 as a marker of prognosis in breast cancer [Letter] |
| title_short | TMED2 as a marker of prognosis in breast cancer [Letter] |
| title_sort | tmed2 as a marker of prognosis in breast cancer [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636177/ https://www.ncbi.nlm.nih.gov/pubmed/31372042 http://dx.doi.org/10.2147/CMAR.S210756 |
| work_keys_str_mv | AT schwarzmegancatherine tmed2asamarkerofprognosisinbreastcancerletter AT allikmetssilvia tmed2asamarkerofprognosisinbreastcancerletter |